Plasticell

Developer of stem cell technologies to discover drugs that regenerate tissues of the human body. The company is developing hematopoietic stem cell therapies for thrombocytopenia, anemia, diabetes, and obesity. The proprietary technology, Combinatorial Cell Culture (CombiCult), is a bead-based high throughput screening platform used to differentiate stem cells into a variety of somatic lineages.